1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Product Development Research Program - Texas Therapeutics Company RFA is sponsored by Cancer Prevention and Research Institute of Texas (CPRIT). CPRIT funds Texas-based companies developing novel products or services to benefit cancer patients. This RFA supports research and development of innovative therapeutics, including those leveraging bioinformatics and artificial intelligence, for cancer treatment.
Funding can support preclinical proof of concept, manufacturing development, and clinical studies (Phase 1 and 2).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Welcome to the Cancer Prevention and Research Institute of Texas Application Receipt System Notification of Scheduled Maintenance The CPRIT Application Receipt System (CARS) and the CPRIT Grants Management System (CGMS) will be undergoing scheduled maintenance At this time, the system will not be available. We apologize for any inconvenience and thank you for your understanding.
I am a returning CPRIT Application Receipt System user I am a new CPRIT Application Receipt System user Please be advised that the RRCTA RFA and IFA documents have been updated to clarify eligibility requirements and review criteria. Please be advised that the REI, RFT, and RRS RFA and IFA documents for FY2026 Academic Research have been updated. View the RFA Release and Peer Review Schedule .
CPRIT now supports ORCID ID's in Applicant Profiles.
AWARD MECHANISMS ACCEPTING APPLICATIONS: Recruitment or Retention of Clinical Trialists Award (RRCTA) Application receipt period: September 9, 2025 - May 20, 2026 Recruitment of First-Time, Tenure - Track Faculty Members (RFT) Recruitment of Rising Stars (RRS) Recruitment of Established Investigators (REI) Application receipt period: June 23, 2025 - June 22, 2026 Cancer Screening and Early Detection (CSD) Primary Prevention of Cancer (PPC) Dissemination of CPRIT-Funded Cancer Control Interventions (DI) Application receipt period: March 18, 2026 - June 10, 2026 Product Development Research Texas Therapeutics Company Awards for Product Development Research (TTC) Texas Diagnostic and Devices Company Awards for Product Development Research (TDDC) Texas New Technologies Company Awards for Product Development Research (TNTC) SEED Awards for Product Development Research (SEED) Application receipt period: Preliminary Applications: April 7, 2026 - April 16, 2026 Full Application Receipt Closing Date: July 9, 2026 View our Statute, Rules and Grant Policies Guide .
CPRIT's guidance to define prevention research and prevention non-research is available here (5/10/12). CGMS Grantee Training slide presentation available . Data Classification Policy v1.
5. 0. pdf Frequently Asked Questions Call or email our HelpDesk Download agreement documents: Electronic User Agreement Tobacco-free Workplace Policy Certification Tobacco-free Workplace Policy Certification Waiver Grantee Resources, Forms and Guidance Documents This is a Cancer Prevention and Research Institute of Texas computer system, which may be accessed and used only for official Government business by authorized personnel.
Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. Any information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Access or use of this computer system by any person whether authorized or unauthorized, constitutes consent to these terms.
Contact the CPRIT Application Receipt System Helpdesk
According to the current listing, eligibility includes: Texas-based companies developing innovative therapeutic products with significant potential impact on patient care. Projects should generally be at a stage where a lead compound has been identified and characterized, with demonstrated efficacy in relevant animal models. Confirm the full requirements in the official notice before applying.
Product Development Research Program - Texas Therapeutics Company RFA is funded by Cancer Prevention and Research Institute of Texas (CPRIT). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Texas. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
HHS has obligated roughly half a percent of the FY2026 Teen Pregnancy Prevention appropriation with days left before September 30. Here is the full timeline, the replacement NOFO that closed in July, the August court ruling, and what grantees should be doing right now.
Read articleThe August 31, 2026 award announcement splits $77 million across ten programs — $22.2 million to prevention, $23.6 million to treatment and recovery, $21.8 million to community mental health, $9.4 million to suicide and crisis. Read against the proposed consolidation of SAMHSA into the Administration for a Healthy America, the breakdown is a priorities map.
Read articleThe FY2026 COPS School Violence Prevention Program offers up to $500,000 per award across roughly 200 grants, with a 25% match and a $100,000 microgrant lane for rural and tribal schools. But the statute limits it to physical security and law enforcement coordination — not mental health. Here is what SVPP actually funds, who can apply, and how to build a competitive application before August 4, 2026.
Read article